Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Ami Organics
Join Channel
Consolidated Standalone

AMI Organics

₹1416.1 -32.2 | 2.2%

Market Cap ₹5796 Cr.

Stock P/E 146.6

P/B 4.9

Current Price ₹1416.1

Book Value ₹ 289.7

Face Value 10

52W High ₹1476

Dividend Yield 0.21%

52W Low ₹ 1005.1

Edit Ratio

AMI Organics Research see more...

Stocx User

Ami Organics Ltd

Overview Inc. Year: 2007Industry: Pharmaceuticals & Drugs

Ami Organics Ltd engages in the R&D, manufacture, and sale of pharmaceutical intermediates in India. The enterprise offers about 450 pharma intermediates to be used in regulated and generic active pharmaceutical components for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-parkinson, anti-depressant, and anti-coagulant packages, in addition to new chemical entities. It additionally offers preservatives, such as parabens and parabens formulations for use in cosmetics, animal meals, and personal care industries; and specialty chemicals for use in cosmetics, dyes, polymers, and agrochemicals. In addition, the company exports its products to approximately 25 nations worldwide. Ami Organics Ltd founded in 2004 and is based in Surat, India.

Read More..

AMI Organics Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

AMI Organics Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

AMI Organics Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 76 112 154 160 188 236 240 341 520 617 688
Other Income 1 0 3 0 3 1 3 1 3 4 14
Total Income 77 112 157 160 191 237 242 342 523 621 701
Total Expenditure 70 103 136 137 158 193 199 260 415 494 580
Operating Profit 7 8 21 23 33 44 44 82 108 127 121
Interest 2 2 3 3 3 5 6 6 6 2 6
Depreciation 1 1 1 1 2 3 4 4 10 12 15
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 -32
Profit Before Tax 4 6 18 19 28 37 35 72 91 112 69
Provision for Tax 1 2 5 7 10 12 7 18 20 29 25
Profit After Tax 3 4 13 12 18 25 27 54 72 83 44
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 3 4 13 12 18 25 27 54 72 83 44
Adjusted Earnings Per Share 0.9 1.3 4 3.8 5.9 7.8 8.7 5.7 19.7 22.9 11.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 12% 26% 24% 25%
Operating Profit CAGR -5% 14% 22% 33%
PAT CAGR -47% -7% 12% 31%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 8% NA% NA% NA%
ROE Average 7% 14% 22% 31%
ROCE Average 10% 18% 23% 29%

AMI Organics Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 11 15 27 39 58 81 108 164 518 587 675
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 1 6 16 14 31 22 20 73 1 0 114
Other Non-Current Liabilities -0 -0 -1 1 1 3 6 8 7 10 15
Total Current Liabilities 26 38 49 55 65 106 95 166 129 163 268
Total Liabilities 38 59 91 109 155 212 228 410 655 759 1071
Fixed Assets 5 6 9 15 15 58 62 161 178 222 357
Other Non-Current Assets 3 5 16 29 54 34 49 37 50 83 243
Total Current Assets 31 48 66 66 87 121 117 213 427 455 471
Total Assets 38 59 91 109 155 212 228 410 655 759 1071

AMI Organics Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 0 0 0 0 3 0 0 3 2 10 30
Cash Flow from Operating Activities -0 -4 10 29 10 22 27 27 -10 56 101
Cash Flow from Investing Activities -2 -4 -14 -19 -27 -25 -24 -101 -122 -20 -337
Cash Flow from Financing Activities 2 9 4 -7 14 3 0 72 140 -14 235
Net Cash Inflow / Outflow -0 0 -0 2 -2 -0 3 -2 8 21 -1
Closing Cash & Cash Equivalent 0 0 0 3 0 0 3 2 10 30 29

AMI Organics Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 0.91 1.3 4.02 3.83 5.85 7.82 8.72 5.71 19.75 22.87 11.85
CEPS(Rs) 1.16 1.53 4.27 4.26 6.46 8.64 9.84 6.16 22.51 26.26 15.83
DPS(Rs) 0 0 0 0 0 0 0 0 3 3 3
Book NAV/Share(Rs) 3.42 4.71 8.72 12.49 18.37 25.75 34.28 17.35 142.16 161.04 182.43
Core EBITDA Margin(%) 8.04 7.42 11.83 14.43 16.23 18.17 17.14 23.55 20.22 19.89 15.66
EBIT Margin(%) 7.73 6.8 13.18 13.71 16.74 17.56 16.83 22.71 18.81 18.59 10.91
Pre Tax Margin(%) 5.66 5.37 11.51 11.66 15.03 15.54 14.5 21.06 17.58 18.2 10.05
PAT Margin (%) 3.76 3.66 8.23 7.52 9.8 10.46 11.46 15.85 13.83 13.51 6.35
Cash Profit Margin (%) 4.81 4.31 8.75 8.37 10.81 11.56 12.93 17.08 15.77 15.51 8.49
ROA(%) 8.85 8.42 16.87 12.03 13.96 13.41 12.48 16.92 13.51 11.79 4.77
ROE(%) 30.26 31.99 59.83 36.07 37.94 35.45 29.06 39.72 21.1 15.09 6.94
ROCE(%) 29.97 25.03 42.73 35.8 37.76 35.02 26.68 33.05 23.88 20.67 10.22
Receivable days 58.46 61.92 72.02 82.89 83.81 95.13 95.48 91.75 98.38 115.98 117.59
Inventory Days 41.85 41.26 39.99 44.82 45.68 51.17 69.31 60.39 60.54 68.46 71.76
Payable days 91.25 94 96.64 128.43 139.26 142.49 169.83 138.33 135.91 141.99 121.8
PER(x) 0 0 0 0 0 0 0 0 50.63 38.86 92.39
Price/Book(x) 0 0 0 0 0 0 0 0 7.03 5.52 6
Dividend Yield(%) 0 0 0 0 0 0 0 0 0.3 0.34 0.27
EV/Net Sales(x) 0.18 0.21 0.2 0.15 0.23 0.27 0.28 0.49 6.81 5.16 6.12
EV/Core EBITDA(x) 2.02 2.87 1.45 1.06 1.32 1.46 1.52 2.04 32.84 25.07 34.64
Net Sales Growth(%) 37.1 46.82 37.55 4.27 17.45 25.17 1.72 42.13 52.71 18.57 11.49
EBIT Growth(%) 40.09 29.09 166.61 8.51 43.4 31.24 -2.47 91.73 26.52 17.15 -34.57
PAT Growth(%) 39.55 42.98 208.94 -4.76 53.04 33.58 11.53 96.57 33.24 15.84 -47.58
EPS Growth(%) 39.55 42.98 208.94 -4.76 53.04 33.58 11.53 -34.48 245.55 15.84 -48.21
Debt/Equity(x) 1.13 1.55 1.08 0.67 0.75 0.66 0.55 0.83 0 0.01 0.3
Current Ratio(x) 1.18 1.26 1.36 1.21 1.33 1.14 1.23 1.28 3.3 2.79 1.76
Quick Ratio(x) 0.75 0.89 0.96 0.85 0.91 0.78 0.68 0.92 2.43 2.06 1.19
Interest Cover(x) 3.73 4.77 7.91 6.67 9.77 8.7 7.22 13.77 15.27 47.49 12.73
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0.05

AMI Organics Shareholding Pattern

# Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 May 2024 Jun 2024
Promoter 41.05 39.41 39.41 39.41 39.41 38.93 39.91 39.91 39.07 35.98
FII 1.84 5.76 6.41 6.36 6.73 7.16 11.65 8.97 10.01 12.92
DII 4.19 3.61 3.72 3.63 5.12 5.94 7.58 6.81 8.81 14.81
Public 52.91 51.22 50.46 50.6 48.74 47.97 40.86 44.31 42.12 36.29
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 141.99 to 121.8days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 35.98%.
  • Company has a low return on equity of 14% over the last 3 years.
  • Stock is trading at 4.9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

AMI Organics News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!